-
公开(公告)号：US10435463B2
公开(公告)日：2019-10-08
申请号：US15508570
申请日：2015-09-07
Applicant: AIMM THERAPEUTICS B.V.
IPC: C07K16/10
Abstract: The invention relates to isolated, synthetic or recombinant antibodies and functional parts thereof specific for hepatitis C virus (HCV). The invention further relates to the use of such antibodies for diagnosis, treatment and prevention of HCV infection.
Search Results
1
records
(took 0.011 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
